documents: FDA-2021-N-0286-0017
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2021-N-0286-0017 | FDA | FDA-2021-N-0286 | TAB A Part 50-56 PRIA as Submitted to OMB RE Memorandum to FDA DMS on Part 50-56 Proposed Rule | Supporting & Related Material | Background Material | 2022-10-04T04:00:00Z | 2022 | 10 | 2022-10-04T13:44:34Z | 0 | 0 | 09000064853a671e |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref